For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk ...

Gastrointestinal (GI) cancers account for 26% of the global cancer incidence and 35% of all cancer-related deaths. Although the top 5 cancers in this group ...

1Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom.

Corresponding Author: Joanna Przybyl, Department of Surgery, McGill University, Cancer Research Program, The Research Institute of the McGill University Health Centre, 1001 Decarie Boulevard, E ...

Cancer remains one of the most complex diseases, with its diverse molecular profiles and cellular compositions posing ...

Tumor heterogeneity remains a formidable obstacle in targeted cancer therapy, often leading to suboptimal treatment outcomes. This study presents an innovative approach that harnesses controlled ...

Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

This can be attributed, at least in part, to the complexity of the tumour microenvironment and its considerable heterogeneity both in terms of the tumour and non-tumour cell components. These ...

While the body of evidence to date shows that alcohol can cause cancer, the data on red wine are less clear-cut.